ABSTRACT

INTRODUCTION In this chapter we describe the current standard of second-line chemotherapy of non-small cell lung cancer (NSCLC) as well as future directions. Second line is here defi ned as therapy after disease progression. Maintenance-defi ned as continued treatment after fi rst-line therapy without tumor progressionwill be discussed in a different chapter.